Psilocybin brain scan study aims to unlock new treatments
Knowledge-focused
Completed
This completed Phase 1 trial tested multiple doses of MLS101, a low-dose psilocybin capsule, in 20 healthy volunteers. Researchers used brain scans (fMRI) to see how the drug affects brain activity, while also checking safety and how the body processes the drug. The goal is to ga…
Phase: PHASE1 • Sponsor: MycoMedica Life Sciences PBC • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC